Completed PHASE2 INTERVENTIONAL 5-arm NCT01215643

Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants

A Multicenter, Randomized, Open Label, Parallel-group Phase IIB Study on the Efficacy and Safety of Oral Regimens of DEB025 Alone or in Combination With Ribavirin Versus Standard of Care (Peg-IFNα2a Plus Ribavirin) in Treatment-naïve Hepatitis C Genotype 2 and 3 Patients

Sponsor: Debiopharm International SA

Conditions Chronic Pain Hepatitis C

Interventions Alisporivir Peginterferon alfa-2a Ribavirin

Updated 9 times since 2017 Last updated: Jul 20, 2016 Started: Oct 31, 2010 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Chronic Pain and Hepatitis C, this trial is completed. The trial is conducted by Debiopharm International SA and has accumulated 9 data snapshots since 2010. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jan 2021 — Dec 2022 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Debiopharm International SA

Data source: Debiopharm International SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Arlington, United States , Bangkok, Thailand , Berlin, Germany , Bialystok, Poland , Bologna, Italy , Brescia, Italy , Brussels, Belgium , Chiang Mai, Thailand , Clayton, Australia , Clichy, France and 52 more locations